Australia Market Report for Uterine Fibroid Embolization Devices 2017 - MedCore

  • ID: 4240683
  • Report
  • Region: Australia
  • 220 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Astec Bio
  • Cook Medical
  • Hologic
  • Kitazato
  • Merit Medical Systems
  • Reproline Medical
  • MORE
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The UFE market has decreased in growth in part because of a reduction in active marketing. Moreover, UFE must compete with a wide array of procedures available to treat heavy bleeding due to uterine fibroids. These other treatments and procedures include hysterectomy, pharmacological alternatives, global endometrial ablation, endometrial resection and other minimally invasive surgical procedures. The complete market is comprised of the microsphere and PVA particle sub-segments respectively. Despiute the overall decrease in the market, the microspheres segment is increasing significantly. The volume of microspheres required per procedure is much higher than the volume of PVA particles required per procedure; 3.5 microspheres are used for every 2 PVA particles required per procedure. The shift towards microspheres has diminished the severity of the drop in unit sales being caused by the declining procedure numbers. Physicians may prefer the use of microspheres over PVA particles due to peer-reviewed journals that outline how microspheres result in reduced blood loss and higher efficacy in the reduction of fibroids compared to the alternative. PVA particles have been popular in the past due to their affordability and they were previously considered the standard of care.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astec Bio
  • Cook Medical
  • Hologic
  • Kitazato
  • Merit Medical Systems
  • Reproline Medical
  • MORE
Executive Summary
Australia Market For Gynecological Devices Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.2 Disease Pathology And Disorders
2.2.1 Introduction
2.2.2 General Diagnostics
2.2.3 Indications For Assisted Reproduction Technologies (Art)
2.2.3.1 Art Cost: Coverage Policy And Medical Insurance In Different Countries
2.2.4 Abnormal Uterine Bleeding
2.2.5 Gynecologic Cancer And Tumors In Reproductive System
2.2.6 Indications For Female Sterilization
2.2.7 Urinary Incontinence
2.2.8 Indications For Pelvic Organ Prolapse Repair
2.2.9 Indications For Co2 Fractional Laser

3. Product Assessment
3.1 Product Portfolios
3.1.1 Uterine Fibroid Embolization
3.1.1.1 Introduction
3.1.1.2 Microspheres
3.1.1.3 Polyvinyl Alcohol Particles
3.1.1.4 Drug-Eluting Particles
3.1.1.5 Product Matrix For Uterine Fibroid Embolization
3.2 Regulatory Issues And Recalls
3.2.1 Uterine Fibroid Embolization
3.3 Clinical Trials
3.3.1 Uterine Fibroid Embolization

4. Uterine Fibroid Embolization Device Market
4.1 Introduction
4.1.1 Microspheres
4.1.2 Polyvinyl Alcohol Particles
4.1.3 Drug-Eluting Particles
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Uterine Fibroid Embolization Device Market
4.3.2 Microsphere Market
4.3.3 Pva Particle Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
Abbreviations
Appendix Ii: Company Press Releases

List Of Charts

Chart 1 1: Gynecological Device Market By Segment, Australia, 2013 - 2023
Chart 1 2: Gynecological Device Market By Segment, Australia, 2016 & 2023
Chart 4 1: Uterine Fibroid Embolization Device Market By Segment, Australia, 2013 - 2023
Chart 4 2: Uterine Fibroid Embolization Device Market Breakdown, Australia, 2016
Chart 4 3: Uterine Fibroid Embolization Device Market Breakdown, Australia, 2023
Chart 4 4: Total Uterine Fibroid Embolization Device Market, Australia, 2013 - 2023
Chart 4 5: Microsphere Market, Australia, 2013 - 2023
Chart 4 6: Pva Particle Market, Australia, 2013 - 2023
Chart 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Australia, 2016

List Of Figures

Figure 1 1 Gynecological Device Market By Segment, Australia, 2016 (1 Of 2)
Figure 1 2: Gynecological Device Market By Segment, Australia, 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, Australia, 2016
Figure 1 4: Factors Impacting The Gynecological Device Market By Segment, Australia (1 Of 2)
Figure 1 5: Factors Impacting The Gynecological Device Market By Segment, Australia (2 Of 2)
Figure 1 6: Recent Events In The Gynecological Device Market, Australia, 2012 - 2016
Figure 1 7: Gynecological Procedure Numbers Covered, Australia, 2016
Figure 1 8: Gynecological Device Markets Covered, Australia, 2016
Figure 1 9: Key Report Updates
Figure 1 10: Version History
Figure 2 1: Gynecological Disease Overview
Figure 2 2: Art Procedure Availability Overview
Figure 2 3: Art Procedure Availability Overview
Figure 3 1: Class 2 Device Recall: Spermmar Test
Figure 3 2: Uterine Fibroid Embolization: Safety And Efficacy Of Embozene Microspheres For Uterine Fibroid Embolization
Figure 3 3: Uterine Fibroid Embolization: Embozene Microspheres For Uterine Fibroid Embolization (Ufe)
Figure 4 1: Uterine Fibroid Embolization Device Market By Segment, Australia, 2013 - 2023 (Au$M)
Figure 4 2: Uterine Fibroid Embolization Device Market By Segment, Australia, 2013 - 2023 (Us$M)
Figure 4 3: Total Uterine Fibroid Embolization Device Market, Australia, 2013 - 2023
Figure 4 4: Microsphere Market, Australia, 2013 - 2023
Figure 4 5: Pva Particle Market, Australia, 2013 - 2023
Figure 4 6: Drivers And Limiters, Uterine Fibroid Embolization Device Market, Australia, 2016
Figure 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Australia, 2016
Figure 6 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astec Bio
  • B-bridge International, Inc.
  • BTG
  • Boston Scientific
  • Carl Zeiss
  • Coloplast
  • Cook Medical
  • Cooper Surgical
  • Ecleris
  • Esco Global
  • FertiPro
  • Hologic
  • Hunter Scientific
  • Irvine Scientific
  • Johnson & Johnson
  • Karl Storz
  • Kitazato
  • Leica
  • Life Global
  • Medgyne
  • Medtronic
  • Merck KGaA - Genea Biomedx
  • Merit Medical Systems
  • Nidacon Medical
  • Olympus
  • Pentax
  • Promis Medical
  • Reproline Medical
  • Richard Wolf
  • Rocket Medical
  • Stryker
  • Vitrolife
  • Vitromed
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll